Madrigal Pharmaceuticals (MDGL) Insider Trading & Ownership $324.64 +4.71 (+1.47%) As of 03:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Madrigal Pharmaceuticals (NASDAQ:MDGL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$23.68 M Get MDGL Insider Trade Alerts Want to know when executives and insiders are buying or selling Madrigal Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MDGL Insider Buying and Selling by Quarter Madrigal Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/5/2025Robert E WaltermireVPSell14,113$341.32$4,817,049.16 2/28/2025Robert E WaltermireVPSell1,227$341.07$418,492.89 2/27/2025James M DalyDirectorSell15,470$347.45$5,375,051.50 1/24/2025Carole HuntsmanInsiderSell347$335.24$116,328.28 1/24/2025Rebecca TaubCMOSell648$335.24$217,235.52 1/24/2025Robert E WaltermireVPSell103$335.24$34,529.72 1/24/2025William John SiboldCEOSell1,584$335.24$531,020.16 1/17/2025Rebecca TaubCMOSell1,689$273.41$461,789.49 1/17/2025Robert E WaltermireVPSell442$273.41$120,847.22 1/17/2025Shannon T KelleyGeneral CounselSell277$273.41$75,734.57 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/3/2024Fred B CravesDirectorSell3,600$315.31$1,135,116.00 11/25/2024Fred B CravesDirectorSell3,400$350.30$1,191,020.00 11/1/2024Richard S LevyDirectorSell5,000$300.94$1,504,700.00 9/9/2024William John SiboldCEOSell6,363$243.83$1,551,490.29 6/14/2024Robert E WaltermireVPSell1,900$280.00$532,000.00 6/12/2024Robert E WaltermireVPSell2,000$285.00$570,000.00 5/21/2024Robert E WaltermireVPSell1,036$231.34$239,668.24 5/14/2024Fred B CravesDirectorSell22,489$212.88$4,787,458.32 (Data available from 1/1/2013 forward) MDGL Insider Trading Activity - Frequently Asked Questions Who is on Madrigal Pharmaceuticals's Insider Roster? The list of insiders at Madrigal Pharmaceuticals includes Brian Joseph Lynch, Bros. Advisors Lp Baker, Carole Huntsman, Fred B Craves, James M Daly, Paul A Friedman, Rebecca Taub, Remy Sukhija, Richard S Levy, Robert E Waltermire, Shannon T Kelley, and William John Sibold. Learn more on insiders at MDGL. What percentage of Madrigal Pharmaceuticals stock is owned by insiders? 22.80% of Madrigal Pharmaceuticals stock is owned by insiders. Learn more on MDGL's insider holdings. Which Madrigal Pharmaceuticals insiders have been buying company stock? The following insider purchased MDGL shares in the last 24 months: Bros. Advisors Lp Baker ($43,382,043.47). How much insider buying is happening at Madrigal Pharmaceuticals? Insiders have purchased a total of 226,067 MDGL shares in the last 24 months for a total of $43,382,043.47 bought. Which Madrigal Pharmaceuticals insiders have been selling company stock? The following insiders have sold MDGL shares in the last 24 months: Brian Joseph Lynch ($1,190,726.00), Carole Huntsman ($116,328.28), Fred B Craves ($7,113,594.32), James M Daly ($8,713,946.03), Paul A Friedman ($11,013,192.90), Rebecca Taub ($14,857,077.71), Richard S Levy ($4,336,980.00), Robert E Waltermire ($7,296,087.23), Shannon T Kelley ($75,734.57), and William John Sibold ($2,082,510.45). How much insider selling is happening at Madrigal Pharmaceuticals? Insiders have sold a total of 236,484 Madrigal Pharmaceuticals shares in the last 24 months for a total of $56,796,177.49 sold. Madrigal Pharmaceuticals Key ExecutivesDr. Rebecca A. Taub M.D. (Age 72)Founder, Chief Medical Officer, President of Research & Development and Director Compensation: $939.83kMr. Brian J. Lynch J.D. (Age 62)Senior VP & General Counsel Compensation: $763.75kMr. Alex G. Howarth (Age 55)Executive Officer Compensation: $757.26kMr. William J. Sibold (Age 58)CEO, President & Director 1 recent tradesMs. Mardi C. Dier (Age 60)CFO, Principal Financial Officer, Principal Accounting Officer & Senior VP Mr. Ronald FilippoChief Information OfficerMs. Tina E. VenturaChief Investor Relations OfficerDr. Kianoush Motesharei Ph.d. (Age 54)Senior Vice President of Business & Corporate Development Mr. Clint WallaceChief Human Resources OfficerMr. Edward ChiangSenior Vice President of Clinical & Technical Operations More Insider Trading Tools from MarketBeat Related Companies Biogen Insider Buying United Therapeutics Insider Buying BioMarin Pharmaceutical Insider Buying Incyte Insider Buying Neurocrine Biosciences Insider Buying Exelixis Insider Buying Exact Sciences Insider Buying Repligen Insider Buying Halozyme Therapeutics Insider Buying Ionis Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:MDGL) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDGL Stock Free MDGL Stock Alerts